<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Womens Health</journal-id><journal-id journal-id-type="iso-abbrev">BMC Womens Health</journal-id><journal-id journal-id-type="pmc-domain-id">68</journal-id><journal-id journal-id-type="pmc-domain">bmcwh</journal-id><journal-title-group><journal-title>BMC Women's Health</journal-title></journal-title-group><issn pub-type="epub">1472-6874</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10369769</article-id><article-id pub-id-type="pmcid-ver">PMC10369769.1</article-id><article-id pub-id-type="pmcaid">10369769</article-id><article-id pub-id-type="pmcaiid">10369769</article-id><article-id pub-id-type="pmid">37491234</article-id><article-id pub-id-type="doi">10.1186/s12905-023-02509-7</article-id><article-id pub-id-type="publisher-id">2509</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by <italic toggle="yes">Corynebacterium kroppenstedtii:</italic> a retrospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Li</surname><given-names initials="S">ShunBo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Huang</surname><given-names initials="Q">Qian</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Song</surname><given-names initials="P">PeiPei</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Han</surname><given-names initials="X">XiaoRong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Z">ZeYu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhou</surname><given-names initials="L">Lin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5799-7030</contrib-id><name name-style="western"><surname>Ning</surname><given-names initials="P">Ping</given-names></name><address><email>nping11@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.54549.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 4060</institution-id><institution>Department of Breast, Chengdu Women&#8217;s and Children&#8217;s Central Hospital, School of Medicine, </institution><institution>University of Electronic Science and Technology of China, </institution></institution-wrap>No.1617, Riyue Avenue 1St Section, Chengdu, Sichuan 611731 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.54549.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 4060</institution-id><institution>School of Medicine, </institution><institution>University of Electronic Science and Technology of China, </institution></institution-wrap>Chengdu, Sichuan 611731 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.54549.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 4060</institution-id><institution>Department of Laboratory, Chengdu Women&#8217;s and Children&#8217;s Central Hospital, School of Medicine, </institution><institution>University of Electronic Science and Technology of China, </institution></institution-wrap>Chengdu, Sichuan 611731 China </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">424955</issue-id><elocation-id>388</elocation-id><history><date date-type="received"><day>3</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>25</day><month>6</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>27</day><month>07</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-27 10:25:09.880"><day>27</day><month>07</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12905_2023_Article_2509.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Increasing evidence has suggested that <italic toggle="yes">Corynebacterium kroppenstedtii</italic> is associated with some cases of granulomatous mastitis, mostly based on pathology or microbiology. We aimed to identify the clinical characteristics and treatment regimens for granulomatous mastitis with <italic toggle="yes">Corynebacterium kroppenstedtii</italic> infection. Understanding these clinical features is essential for patient care.</p></sec><sec><title>Methods</title><p id="Par2">We retrospectively collected data on 201 patients who were pathologically diagnosed with granulomatous mastitis and had microbiological results of either <italic toggle="yes">Corynebacterium kroppenstedtii</italic> or no bacterial growth and recorded and analysed their demographics, clinical characteristics, and clinical outcomes.</p></sec><sec><title>Results</title><p id="Par3">There were 107 patients in the CK group and 94 patients in the negative group. Sinus formation (x<sup>2</sup>&#8201;=&#8201;13.028, <italic toggle="yes">p</italic>&#8201;=&#8201;0.000), time to complete remission at the first treatment period (Z&#8201;=&#8201;-3.027, <italic toggle="yes">p</italic>&#8201;=&#8201;0.002), diameter of breast mass at first-time medical consultancy (Z&#8201;=&#8201;-2.539, <italic toggle="yes">p</italic>&#8201;=&#8201;0.011) and recurrence (x<sup>2</sup>&#8201;=&#8201;4.953, <italic toggle="yes">p</italic>&#8201;=&#8201;0.026) were statistically significant. Age (Z&#8201;=&#8201;-1.046, <italic toggle="yes">p</italic>&#8201;=&#8201;0.295), laterality (x<sup>2</sup>&#8201;=&#8201;4.217, <italic toggle="yes">p</italic>&#8201;=&#8201;0.121), time to presentation since the last delivery (x<sup>2</sup>&#8201;=&#8201;0.028, <italic toggle="yes">p</italic>&#8201;=&#8201;0.868), BMI (Z&#8201;=&#8201;-0.947, <italic toggle="yes">p</italic>&#8201;=&#8201;0.344), lactation time (Z&#8201;=&#8201;-1.378, <italic toggle="yes">p</italic>&#8201;=&#8201;0.168), parity (x<sup>2</sup>&#8201;=&#8201;1.799, <italic toggle="yes">p</italic>&#8201;=&#8201;0.180), gravida (Z&#8201;=&#8201;-0.144, <italic toggle="yes">p</italic>&#8201;=&#8201;0.885), history of lactational mastitis or abscess (x<sup>2</sup>&#8201;=&#8201;0.115, <italic toggle="yes">p</italic>&#8201;=&#8201;0.734), local trauma (x<sup>2</sup>&#8201;=&#8201;0.982, <italic toggle="yes">p</italic>&#8201;=&#8201;0.322), hyperprolactinemia (x<sup>2</sup>&#8201;=&#8201;0.706, <italic toggle="yes">p</italic>&#8201;=&#8201;0.401), erythema nodosum (x<sup>2</sup>&#8201;=&#8201;0.292, <italic toggle="yes">p</italic>&#8201;=&#8201;0.589), and nipple discharge (x<sup>2</sup>&#8201;=&#8201;0.281, <italic toggle="yes">p</italic>&#8201;=&#8201;0.596) did not demonstrate statistical significance. Regarding recurrence related to therapeutic strategy, except for surgery combined with immunosuppressants (x<sup>2</sup>&#8201;=&#8201;9.110, <italic toggle="yes">p</italic>&#8201;=&#8201;0.003), which was statistically significant, none of the other treatment regimens reached statistical significance. The recurrence rate of patients in the CK group using rifampicin in their treatment course was 22.0% (x<sup>2</sup>&#8201;=&#8201;4.892, <italic toggle="yes">p</italic>&#8201;=&#8201;0.027).</p></sec><sec><title>Conclusions</title><p id="Par4">Granulomatous mastitis accompanied by <italic toggle="yes">Corynebacterium kroppenstedtii</italic> more easily forms sinuses and has a higher recurrence rate. Both of the clinical characteristics may indicate that <italic toggle="yes">Corynebacterium kroppenstedtii</italic> plays an important role in the development and progression of granulomatous mastitis. Lipophilic antibiotics may be essential for granulomatous mastitis with <italic toggle="yes">Corynebacterium kroppenstedtii</italic> infection.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Granulomatous mastitis</kwd><kwd><italic toggle="yes">Corynebacterium kroppenstedtii</italic></kwd><kwd>Clinical characteristics</kwd><kwd>Therapeutic strategy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par10">Granulomatous mastitis (GM) is a rare inflammatory disease of the postlactation breast that clinically mimics breast cancer [<xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR5">5</xref>]. Recently, GM has become increasingly prevalent in China [<xref ref-type="bibr" rid="CR6">6</xref>]. Its clinical presentation can be variable, ranging from acute infective episodes such as abscess or mastitis to breast lump resembling malignancy [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Sometimes, erythema nodosum and arthritis occur as extramammary presentations of GM [<xref ref-type="bibr" rid="CR9">9</xref>]. The aetiology of GM is still unknown, and may be due to autoimmunity, microbiological agents, smoking, oral contraceptive pills, ethnicity, &#945;1-antitrypsin deficiency and hormonal imbalance such as hyperprolactinemia [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par11">Recent studies have found that particular <italic toggle="yes">Corynebacterium</italic> may be involved in the pathogenesis of some cases of GM [<xref ref-type="bibr" rid="CR12">12</xref>]. <italic toggle="yes">Corynebacterium kroppenstedtii</italic> (<italic toggle="yes">C. kroppenstedtii</italic>, CK) is a lipophilic <italic toggle="yes">Corynebacterium</italic> first described in 1998 after isolation from a sputum specimen [<xref ref-type="bibr" rid="CR13">13</xref>]. In 2002, <italic toggle="yes">C. kroppenstedtii</italic> was first described in a retrospective case series of histologically proven granulomatous lobar mastitis in predominantly young Polynesian women, and accounted for 40% of isolates recovered from these patients [<xref ref-type="bibr" rid="CR12">12</xref>]. Since then, <italic toggle="yes">C. kroppenstedtii</italic> has been reported in multiple case reports and case series associated with GM [<xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>], typically in young parous women [<xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR20">20</xref>]. <italic toggle="yes">C. kroppenstedtii</italic> can be identified by whole genome sequencing, matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS), and 16S rRNA sequencing. MALDI-TOF MS has largely supplanted gene sequencing due to the higher cost, greater technical complexity, and prolonged turnaround time associated with gene sequencing [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Recently, there has been increasing evidence of an association between corynebacterial infection and a distinct pattern termed cystic neutrophilic GM, characterized by lipogranulomas consisting of clear spaces rimmed by neutrophils and surrounding granulomatous inflammation [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR23">23</xref>&#8211;<xref ref-type="bibr" rid="CR28">28</xref>]. However, nearly all of these studies focused on pathological microorganisms, and few studies analysed the clinical features and the best treatment methods of GM patients infected with <italic toggle="yes">C. kroppenstedtii</italic>. Therefore, here, we retrospectively collected all patients who were pathologically diagnosed with GM for the first time in our hospital from 2018 to 2021 and had microbiological results, completed treatment plans and achieved cure, which was defined as breast lesions completely disappearing with surgery or drugs at least one time. Their clinical signs, management, clinical course, and clinical outcomes were collected and analysed.</p><p id="Par12">Our study attempted to determine the clinical characteristics and better therapeutic strategy of GM with <italic toggle="yes">C. kroppenstedtii</italic> infection, not only to deepen and complete the understanding of the clinical features of GM with <italic toggle="yes">C. kroppenstedtii</italic> infection in the literature, but also to provide direct and objective evidence of <italic toggle="yes">C. kroppenstedtii</italic> in the development and progression of GM.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Ethical approval</title><p id="Par13">The Institutional Review Board of Chengdu Women's and Children's Central Hospital approved this study (reference number 2022(96)). The requirement for patient consent to participate in this study was waived because of the retrospective nature of the study. Information was gathered from electrical medical systems in an anonymous manner, where all authors could ensure the confidentiality of patient data. The study followed the latest version of the Helsinki Declaration.</p></sec><sec id="Sec4"><title>Study subjects</title><p id="Par14">Our study included patients who were treated in the Breast Department of Chengdu Women&#8217;s and Children&#8217;s Central Hospital between January 2018 and June 2021. The follow-up time ranged from 13 to 42&#160;months. Eligibility criteria: a) pathologically diagnosed as GM, which means the histopathologic features are noncaseating granulomas centred on lobules, with or without associated microabscesses; b) accompanied by abscess formation throughout the course of the disease; c) routine bacterial culture (culture conditions: blood agar culture-medium, 35 degrees Celsius) of pus and MALDI-TOF MS to identify if the bacteria was <italic toggle="yes">C. kroppenstedtii</italic>; d) complete remission, which was defined as no residual lesions both clinically and ultrasonically at least one time. The exclusion criteria were as follows: a) evidence of other bacteria, b) pregnancy, and c) psychiatric illness.</p></sec><sec id="Sec5"><title>Study data</title><p id="Par15">The patients&#8217; medical records were retrieved from not only outpatient but also inpatient departments. We recorded their age, laterality, gravidity, parity, BMI, mental illness, time to presentation since last delivery and breast feeding, history of lactational mastitis or abscess, local trauma, bacterial results, serum prolactin levels and clinical findings (including diameter of breast mass at first-time medical consultancy, sinus formation, erythema nodosum, and nipple discharge), management protocols (including immunosuppressants such as steroids and methotrexate, surgery, antibiotics (antituberculosis drugs rifampicin)), time to complete remission at the first treatment periods, and recurrence. All patients were assessed by physical examination, laboratory tests and ultrasonography (USG) during the follow-up period. At the same time, we collected more information of interest from our follow-up centre, such as lactation time and recurrence which was defined as the appearance of new lesions either clinically or ultrasonically after complete remission, and the new lesions were pathologically confirmed as granulomatous mastitis. The data were analysed retrospectively.</p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par16">Data are presented as medians and ranges for quantitative variables and as numbers or percentages for qualitative variables. Quantitative data between the groups were first tested for normality and compared using the Mann&#8211;Whitney U test. The chi-square test, Fisher&#8217;s exact test and Mann&#8211;Whitney U test were used to compare qualitative data. A <italic toggle="yes">p</italic> value of&#8201;&lt;&#8201;0.05 was considered statistically significant. All statistical analyses were performed using the SPSS statistical software package version 23.0.</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par17">In total, 201 patients were enrolled in our study, and they were all Chinese parous women aged 23 to 52. There were 107 patients in the CK group (defined as those with <italic toggle="yes">C. kroppenstedtii</italic> infection) and 94 patients in the negative group (defined as those with no evidence of bacteria). Most patients had normal BMI and their baby was 5&#160;years old or younger when they were diagnosed with GM. The majority of enrolled patients had only one child and nearly half of them lactated for 7&#8211;12&#160;months. The details of demographics and clinical characteristics, including recurrence, are presented in Table <xref rid="Tab1" ref-type="table">1</xref>, but some data on lactation time were missing for 18 patients in the CK group and 16 in the negative group. Recurrence related to treatment methods is presented in Tables&#160;<xref rid="Tab2" ref-type="table">2</xref> and&#160;<xref rid="Tab3" ref-type="table">3</xref>.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Demographics and clinical characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Characteristics</th><th align="left" colspan="1" rowspan="1">Total <italic toggle="yes">N</italic>&#8201;=&#8201;201</th><th align="left" colspan="1" rowspan="1">CK<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;107)</th><th align="left" colspan="1" rowspan="1">N<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;94)</th><th align="left" colspan="1" rowspan="1">P</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><bold>Age in year</bold></td><td align="left" colspan="1" rowspan="1">31 (23&#8211;52)</td><td align="left" colspan="1" rowspan="1">31 (23&#8211;48)</td><td align="left" colspan="1" rowspan="1">32 (23&#8211;52)</td><td align="left" colspan="1" rowspan="1">0.295</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Laterality</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.121</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Left</td><td align="left" colspan="1" rowspan="1">105 (52.2%)</td><td align="left" colspan="1" rowspan="1">52 (48.6%)</td><td align="left" colspan="1" rowspan="1">53 (56.4%)</td><td align="left" rowspan="3" colspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Right</td><td align="left" colspan="1" rowspan="1">85 (42.3%)</td><td align="left" colspan="1" rowspan="1">46 (43.0%)</td><td align="left" colspan="1" rowspan="1">39 (41.5%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Bilateral</td><td align="left" colspan="1" rowspan="1">11 (5.5%)</td><td align="left" colspan="1" rowspan="1">9 (8.4%)</td><td align="left" colspan="1" rowspan="1">2 (2.1%)</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Diameter (cm)</bold></td><td align="left" colspan="1" rowspan="1">5.5 (2.0&#8211;17.0)</td><td align="left" colspan="1" rowspan="1">6.0 (2.0&#8211;17.0)</td><td align="left" colspan="1" rowspan="1">5.0 (2.0&#8211;17.0)</td><td align="left" colspan="1" rowspan="1">0.011</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>BMI (kg/m</bold><sup><bold>2</bold></sup><bold>)</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.344</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8201;&lt;&#8201;18.5</td><td align="left" colspan="1" rowspan="1">14 (7.0%)</td><td align="left" colspan="1" rowspan="1">7 (6.5%)</td><td align="left" colspan="1" rowspan="1">7 (7.4%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;18.6&#8211;24.9</td><td align="left" colspan="1" rowspan="1">144 (71.6%)</td><td align="left" colspan="1" rowspan="1">74 (69.2%)</td><td align="left" colspan="1" rowspan="1">70 (74.5%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;25&#8211;29.9</td><td align="left" colspan="1" rowspan="1">35 (17.4)</td><td align="left" colspan="1" rowspan="1">22 (20.6%)</td><td align="left" colspan="1" rowspan="1">13 (13.8%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8201;&#8805;&#8201;30</td><td align="left" colspan="1" rowspan="1">8 (4.0%)</td><td align="left" colspan="1" rowspan="1">4 (3.7%)</td><td align="left" colspan="1" rowspan="1">4 (4.3%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Time to presentation since the last delivery(year)</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.868</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8201;&#8804;&#8201;5</td><td align="left" colspan="1" rowspan="1">181 (90.0%)</td><td align="left" colspan="1" rowspan="1">96 (89.7%)</td><td align="left" colspan="1" rowspan="1">85 (90.4%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8201;&gt;&#8201;5</td><td align="left" colspan="1" rowspan="1">20 (10.0%)</td><td align="left" colspan="1" rowspan="1">11 (10.3%)</td><td align="left" colspan="1" rowspan="1">9 (9.6%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Lactation time(month)</bold><sup>a</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.168</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;0</td><td align="left" colspan="1" rowspan="1">11 (6.6%)</td><td align="left" colspan="1" rowspan="1">6 (6.7%)</td><td align="left" colspan="1" rowspan="1">5 (6.4%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;1&#8211;6</td><td align="left" colspan="1" rowspan="1">45 (26.9%)</td><td align="left" colspan="1" rowspan="1">19 (21.3%)</td><td align="left" colspan="1" rowspan="1">26 (33.3%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;7&#8211;12</td><td align="left" colspan="1" rowspan="1">80 (47.9%)</td><td align="left" colspan="1" rowspan="1">46 (51.7%)</td><td align="left" colspan="1" rowspan="1">34 (43.6%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;13&#8211;18</td><td align="left" colspan="1" rowspan="1">23 (13.8%)</td><td align="left" colspan="1" rowspan="1">12 (13.5%)</td><td align="left" colspan="1" rowspan="1">11 (14.1%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;19&#8211;24</td><td align="left" colspan="1" rowspan="1">6 (3.6%)</td><td align="left" colspan="1" rowspan="1">5 (5.6%)</td><td align="left" colspan="1" rowspan="1">1 (1.3%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8201;&gt;&#8201;24</td><td align="left" colspan="1" rowspan="1">2 (1.2%)</td><td align="left" colspan="1" rowspan="1">1 (1.1%)</td><td align="left" colspan="1" rowspan="1">1 (1.3%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;missing</td><td align="left" colspan="1" rowspan="1">34 (16.9%)</td><td align="left" colspan="1" rowspan="1">18 (16.8%)</td><td align="left" colspan="1" rowspan="1">16 (17.0%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Parity</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.180</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;1</td><td align="left" colspan="1" rowspan="1">156 (77.6%)</td><td align="left" colspan="1" rowspan="1">87 (81.3%)</td><td align="left" colspan="1" rowspan="1">69 (73.4%)</td><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8201;&gt;&#8201;1</td><td align="left" colspan="1" rowspan="1">45 (22.4%)</td><td align="left" colspan="1" rowspan="1">20 (18.7%)</td><td align="left" colspan="1" rowspan="1">25 (26.6%)</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Gravidity</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.855</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;1</td><td align="left" colspan="1" rowspan="1">66 (32.8%)</td><td align="left" colspan="1" rowspan="1">37 (34.6%)</td><td align="left" colspan="1" rowspan="1">29 (30.9%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;2</td><td align="left" colspan="1" rowspan="1">73 (36.3%)</td><td align="left" colspan="1" rowspan="1">36 (33.6%)</td><td align="left" colspan="1" rowspan="1">37 (39.4%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;3</td><td align="left" colspan="1" rowspan="1">35 (17.4%)</td><td align="left" colspan="1" rowspan="1">19 (17.8%)</td><td align="left" colspan="1" rowspan="1">16 (17.0%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8201;&#8805;&#8201;4</td><td align="left" colspan="1" rowspan="1">27 (13.4%)</td><td align="left" colspan="1" rowspan="1">15 (14.0%)</td><td align="left" colspan="1" rowspan="1">12 (12.8%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Lactational mastitis</bold></td><td align="left" colspan="1" rowspan="1">34 (16.9%)</td><td align="left" colspan="1" rowspan="1">19 (17.8%)</td><td align="left" colspan="1" rowspan="1">15 (16.0%)</td><td align="left" colspan="1" rowspan="1">0.734</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Local trauma</bold></td><td align="left" colspan="1" rowspan="1">17 (8.5%)</td><td align="left" colspan="1" rowspan="1">11 (10.3%)</td><td align="left" colspan="1" rowspan="1">6 (6.4%)</td><td align="left" colspan="1" rowspan="1">0.322</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Hyperprolactinemia</bold></td><td align="left" colspan="1" rowspan="1">37 (18.4%)</td><td align="left" colspan="1" rowspan="1">22 (20.6%)</td><td align="left" colspan="1" rowspan="1">15 (16.0%)</td><td align="left" colspan="1" rowspan="1">0.401</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Erythema nodosum</bold></td><td align="left" colspan="1" rowspan="1">9 (4.5%)</td><td align="left" colspan="1" rowspan="1">4 (3.7%)</td><td align="left" colspan="1" rowspan="1">5 (5.3%)</td><td align="left" colspan="1" rowspan="1">0.589</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Sinus formation</bold></td><td align="left" colspan="1" rowspan="1">100 (49.8%)</td><td align="left" colspan="1" rowspan="1">66 (61.7%)</td><td align="left" colspan="1" rowspan="1">34 (36.2%)</td><td align="left" colspan="1" rowspan="1">0.000</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Nipple discharge</bold></td><td align="left" colspan="1" rowspan="1">15 (7.5%)</td><td align="left" colspan="1" rowspan="1">7 (6.5%)</td><td align="left" colspan="1" rowspan="1">8 (8.5%)</td><td align="left" colspan="1" rowspan="1">0.596</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Time to complete remission (month)</bold></td><td align="left" colspan="1" rowspan="1">5.0 (1.0&#8211;24.0)</td><td align="left" colspan="1" rowspan="1">6.0 (1.0&#8211;24.0)</td><td align="left" colspan="1" rowspan="1">4.0 (1.0&#8211;24.0)</td><td align="left" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Recurrence</bold></td><td align="left" colspan="1" rowspan="1">52 (25.9%)</td><td align="left" colspan="1" rowspan="1">35 (32.7%)</td><td align="left" colspan="1" rowspan="1">17 (18.1%)</td><td align="left" colspan="1" rowspan="1">0.018</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">CK</italic> the <italic toggle="yes">Corynebacterium kroppenstedtii</italic> group</p><p><italic toggle="yes">N</italic> the negative group</p><p><italic toggle="yes">BMI</italic> Body mass index</p><p><sup>a</sup>Data were missing for some patients</p></table-wrap-foot></table-wrap><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Recurrence related to treatment methods</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Treatment</th><th align="left" colspan="1" rowspan="1">Patients</th><th align="left" colspan="1" rowspan="1">Recurrence</th><th align="left" colspan="1" rowspan="1">CK</th><th align="left" colspan="1" rowspan="1">N</th><th align="left" colspan="1" rowspan="1">P</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><bold>IM&#8201;+&#8201;antibiotics&#8201;+&#8201;surgery</bold></td><td align="left" colspan="1" rowspan="1">23 (11.4%)</td><td align="left" colspan="1" rowspan="1">6 (26.1%)</td><td align="left" colspan="1" rowspan="1">4/19 (21.1%)</td><td align="left" colspan="1" rowspan="1">2/4 (50.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.270</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>IM&#8201;+&#8201;surgery</bold></td><td align="left" colspan="1" rowspan="1">107 (53.2%)</td><td align="left" colspan="1" rowspan="1">30 (28.0%)</td><td align="left" colspan="1" rowspan="1">18/40 (45.0%)</td><td align="left" colspan="1" rowspan="1">12/67 (17.9%)</td><td char="." align="char" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>antibiotics&#8201;+&#8201;surgery</bold></td><td align="left" colspan="1" rowspan="1">9 (4.5%)</td><td align="left" colspan="1" rowspan="1">3 (33.3%)</td><td align="left" colspan="1" rowspan="1">3/5 (60.0%)</td><td align="left" colspan="1" rowspan="1">0/4 (0.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.167</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>IM</bold></td><td align="left" colspan="1" rowspan="1">26 (13.0%)</td><td align="left" colspan="1" rowspan="1">9 (34.6%)</td><td align="left" colspan="1" rowspan="1">6/17 (35.3%)</td><td align="left" colspan="1" rowspan="1">3/9 (33.3%)</td><td char="." align="char" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>antibiotics</bold></td><td align="left" colspan="1" rowspan="1">9 (4.5%)</td><td align="left" colspan="1" rowspan="1">0 (0.0%)</td><td align="left" colspan="1" rowspan="1">0/5 (0.0%)</td><td align="left" colspan="1" rowspan="1">0/4 (0.0%)</td><td char="." align="char" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>IM&#8201;+&#8201;antibiotics</bold></td><td align="left" colspan="1" rowspan="1">27 (13.4%)</td><td align="left" colspan="1" rowspan="1">4 (14.8%)</td><td align="left" colspan="1" rowspan="1">4/21 (19.0%)</td><td align="left" colspan="1" rowspan="1">0/6 (0.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.545</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">IM</italic> Immunosuppressants</p><p><italic toggle="yes">CK</italic> the <italic toggle="yes">Corynebacterium kroppenstedtii</italic> group</p><p><italic toggle="yes">N</italic> the negative group</p></table-wrap-foot></table-wrap><table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Recurrence related to antibiotics (rifampicin) in CK group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Group</th><th align="left" colspan="1" rowspan="1">Patients</th><th align="left" colspan="1" rowspan="1">Recurrence</th><th align="left" colspan="1" rowspan="1">No recurrence</th><th align="left" colspan="1" rowspan="1">P</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><bold>A</bold></td><td align="left" colspan="1" rowspan="1">50</td><td align="left" colspan="1" rowspan="1">11 (22.0%)</td><td align="left" colspan="1" rowspan="1">39 (78.0%)</td><td align="left" rowspan="2" colspan="1">0.027</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>B</bold></td><td align="left" colspan="1" rowspan="1">57</td><td align="left" colspan="1" rowspan="1">24 (42.1%)</td><td align="left" colspan="1" rowspan="1">33 (57.9%)</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">CK Corynebacterium kroppenstedtii</italic></p><p><italic toggle="yes">A</italic> management protocols that included rifampicin</p><p><italic toggle="yes">B</italic> management protocols that did not include rifampicin</p></table-wrap-foot></table-wrap></p><p id="Par18">Table <xref rid="Tab1" ref-type="table">1</xref> shows that the median age of all patients was 31&#160;years, with 31&#160;years in the CK group and 32&#160;years in the negative group (Z&#8201;=&#8201;-1.046, <italic toggle="yes">p</italic>&#8201;=&#8201;0.295). Eleven (5.5%) patients had bilateral lesions, and the others were all unilateral (x<sup>2</sup>&#8201;=&#8201;4.217, <italic toggle="yes">p</italic>&#8201;=&#8201;0.121). The median diameter of the mass on the first medical consultation in our study was 5.5&#160;cm, 6.0&#160;cm in the CK group and 5.0&#160;cm in the negative group (Z&#8201;=&#8201;-2.539, <italic toggle="yes">p</italic>&#8201;=&#8201;0.011). Sinus formation (x<sup>2</sup>&#8201;=&#8201;13.028, <italic toggle="yes">p</italic>&#8201;=&#8201;0.000) and recurrence (x<sup>2</sup>&#8201;=&#8201;4.953, <italic toggle="yes">p</italic>&#8201;=&#8201;0.026) were statistically significant, and both were more frequent in the CK group. However, time to presentation since the last delivery (x<sup>2</sup>&#8201;=&#8201;0.028, <italic toggle="yes">p</italic>&#8201;=&#8201;0.868), BMI (Z&#8201;=&#8201;-0.947, <italic toggle="yes">p</italic>&#8201;=&#8201;0.344), lactation time (Z&#8201;=&#8201;-1.378, <italic toggle="yes">p</italic>&#8201;=&#8201;0.168), parity (x<sup>2</sup>&#8201;=&#8201;1.799, <italic toggle="yes">p</italic>&#8201;=&#8201;0.180), gravida (Z&#8201;=&#8201;-0.144, <italic toggle="yes">p</italic>&#8201;=&#8201;0.885), history of lactational mastitis or abscess (x<sup>2</sup>&#8201;=&#8201;0.115, <italic toggle="yes">p</italic>&#8201;=&#8201;0.734), local trauma (x<sup>2</sup>&#8201;=&#8201;0.982, <italic toggle="yes">p</italic>&#8201;=&#8201;0.322), hyperprolactinemia (x<sup>2</sup>&#8201;=&#8201;0.706, <italic toggle="yes">p</italic>&#8201;=&#8201;0.401), erythema nodosum (x<sup>2</sup>&#8201;=&#8201;0.292, <italic toggle="yes">p</italic>&#8201;=&#8201;0.589), and nipple discharge (x<sup>2</sup>&#8201;=&#8201;0.281, <italic toggle="yes">p</italic>&#8201;=&#8201;0.596) did not demonstrate statistical significance. The median time to complete remission at the first treatment period in our study was 5.0&#160;months, ranging from 1.0 to 24.0&#160;months, 6.0&#160;months in the CK group, and 4.0&#160;months in the negative group (Z&#8201;=&#8201;-3.027, <italic toggle="yes">p</italic>&#8201;=&#8201;0.002).</p><p id="Par19">Table <xref rid="Tab2" ref-type="table">2</xref> shows the different treatment strategies in our study, including surgery combined with antibiotics and immunosuppressants, surgery combined with immunosuppressants, surgery combined with antibiotics, immunosuppressants combined with antibiotics, immunosuppressants alone, and antibiotics alone. More than 50% (107) of the patients underwent surgery combined with immunosuppressants, and 30 (28.0%) patients suffered from recurrence; 18 (45.0%) in the CK group and 12 (17.9%) in the negative group (x<sup>2</sup>&#8201;=&#8201;9.110, <italic toggle="yes">p</italic>&#8201;=&#8201;0.003). None of the patients who received antibiotics alone suffered from recurrence. However, surgery combined with antibiotics and immunosuppressants (Fisher&#8217;s exact test, <italic toggle="yes">p</italic>&#8201;=&#8201;0.270), surgery combined with antibiotics (Fisher&#8217;s exact test, <italic toggle="yes">p</italic>&#8201;=&#8201;0.167), immunosuppressants combined with antibiotics (Fisher&#8217;s exact test, <italic toggle="yes">p</italic>&#8201;=&#8201;0.545), and immunosuppressants alone (Fisher&#8217;s exact test, <italic toggle="yes">p</italic>&#8201;=&#8201;1.000) were not statistically significant.</p><p id="Par20">Patients in the CK group were divided into Groups A and B according to whether they used rifampicin in their treatment course, and Group A was defined as management protocols that included rifampicin, and Group B was defined as management protocols that did not include rifampicin. The recurrence rate was 22.0% in Group A and 42.1% in Group B (x<sup>2</sup>&#8201;=&#8201;4.892, <italic toggle="yes">p</italic>&#8201;=&#8201;0.027) (Table <xref rid="Tab3" ref-type="table">3</xref>).</p></sec><sec id="Sec8"><title>Discussion</title><p id="Par21"><italic toggle="yes">C. kroppenstedtii</italic> is an unusual member of the genus Corynebacterium first described in 1998 as it lacks the characteristic mycolic acids in the cell envelope [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>]. The <italic toggle="yes">C. kroppenstedtii</italic> type strain has revealed a lipophilic (lipid-requiring) lifestyle and a remarkable repertoire of carbohydrate uptake and utilization systems [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Breasts are made of fat and glands and are full of lipids. Sue Paviour et al. found that <italic toggle="yes">Corynebacteria</italic> were isolated from breast tissue, pus, or deep wound swabs of 24 women; the most common species isolated was the newly described <italic toggle="yes">C. kroppenstedtii</italic> [<xref ref-type="bibr" rid="CR12">12</xref>]. The rich lipid environment of the breast is conducive to the growth and reproduction of <italic toggle="yes">C. kroppenstedtii</italic> [<xref ref-type="bibr" rid="CR33">33</xref>&#8211;<xref ref-type="bibr" rid="CR35">35</xref>]. Thus, the breast is a favourable environment for the development of lipophilic corynebacteria. Moreover, P. Kieffer et al. thought that mammary areas rich in lipids or malformations such as ductal ectasia can be a factor favour the development of GM [<xref ref-type="bibr" rid="CR15">15</xref>]. Therefore, lipid-rich breast tissue provides the perfect habitat for <italic toggle="yes">C. kroppenstedtii</italic> to reside and form granulomas and abscesses [<xref ref-type="bibr" rid="CR36">36</xref>]. According to recent studies, increasing evidence has confirmed that GM is closely related to <italic toggle="yes">C. kroppenstedtii</italic>. Yu HJ et al. confirmed the predominance of <italic toggle="yes">C. kroppenstedtii</italic> infection in GM patients (11 of 19 patients, 57.9%) with Sanger sequencing and qPCR assays [<xref ref-type="bibr" rid="CR13">13</xref>]. Tariq et al. found that <italic toggle="yes">C. kroppenstedtii</italic> 16S rRNA real-time polymerase chain reaction was positive on formalin-fixed, paraffin-embedded tissues from 46 of 67 (68.7%) GM cases [<xref ref-type="bibr" rid="CR37">37</xref>]. Li XQ et al. achieved a detection rate of <italic toggle="yes">C. kroppenstedtii</italic> up to 56% in the nanopore sequencing method [<xref ref-type="bibr" rid="CR38">38</xref>]. In our study, using MALDI-TOF MS, <italic toggle="yes">C. kroppenstedtii</italic> was confirmed in more than 50% of patients as well.</p><p id="Par22">From our study, 61.7% of patients in the CK group formed sinuses, compared to the negative group, and patients in the CK group seemed to be more likely to form sinuses, which means that sinus formation was more common in GM with <italic toggle="yes">C. kroppenstedtii</italic> in our study than in those with no evidence of bacteria. Taylor et al. conducted research on a case group (34 patients with <italic toggle="yes">Corynebacterium</italic> spp.) versus the control group (28 patients with no evidence of Corynebacteria) and found that the formation of draining sinuses was significantly different between the two groups and was more frequent in the case group [<xref ref-type="bibr" rid="CR1">1</xref>]. Bi JX et al. found that 16 of 25 (64.00%) patients diagnosed with GM in their study had skin ulceration and pus, and 9 of them (56.25%) with skin ulceration had the pathogen <italic toggle="yes">C. kroppenstedtii</italic> [<xref ref-type="bibr" rid="CR33">33</xref>]. <italic toggle="yes">C. kroppenstedtii</italic> preferred to grow and proliferate in lipid-rich areas of the breast, including the subcutaneous area, first forming small and scattered localized abscesses and then gradually expanding and infiltrating the subcutaneous area and forming sinuses. Thus, it is much easier for GM to form sinuses with <italic toggle="yes">C. kroppenstedtii</italic> infection.</p><p id="Par23">Except for sinus formation, we also found that recurrence may be associated with <italic toggle="yes">C. kroppenstedtii</italic>. In our study, a total of 52 patients (25.9%) suffered from recurrence, and among them, 35 patients were found to be positive for <italic toggle="yes">C. kroppenstedtii</italic>. In the literature, there is a recurrence rate of approximately 24.8% for GM whether <italic toggle="yes">C. kroppenstedtii</italic> infection or not [<xref ref-type="bibr" rid="CR39">39</xref>]. Some studies also reported that the presence of <italic toggle="yes">C. kroppenstedtii</italic> was a significant prognosticator for recurrence [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Azizi A et al. found that breast skin lesions were associated with significantly higher odds of recurrence, but unfortunately, there was no further exploration with <italic toggle="yes">C. kroppenstedtii</italic> [<xref ref-type="bibr" rid="CR39">39</xref>]. In conclusion, GM accompanied by <italic toggle="yes">C. kroppenstedtii</italic> is much easier to recur. Given the high rate of recurrence, close long-term follow-up must be emphasized [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par24">According to the literature, the most common treatments used in <italic toggle="yes">C. kroppenstedtii</italic> breast infections are surgery, steroids, and antibiotics, but their individual and combined impact is unclear [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. In addition, close observation might be the optional management for GM [<xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR44">44</xref>]. Godazandeh carried out a meta-analysis and reported that the combination of steroids and surgery was more effective than steroids only [<xref ref-type="bibr" rid="CR45">45</xref>]. Additionally, most Chinese experts agreed that corticosteroid combined surgery was used as the primary treatment for GM [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Methotrexate is a treatment option for patients who have relapsed or who do not tolerate high-dose corticosteroid therapy [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Surgery was performed depending on the individual clinical efficacy and the choice of surgical technique varied from wide excision to mastectomy even with transverse rectus abdominis musculocutaneous (TRAM) flaps, in the literature [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Hazel C. Dobinson et al. considered that if granulomatous disease is present, it seems prudent to choose agents that are both active against Corynebacterium spp. and have physicochemical properties that would promote activity within the lipid-filled spaces. Preferred choices include clarithromycin and rifampicin, which are also active in other granulomatous infections such as mycobacterial infections [<xref ref-type="bibr" rid="CR2">2</xref>]. In our study, we tried multiple treatment strategies including surgery combined with antibiotics and immunosuppressants, surgery combined with immunosuppressants, surgery combined with antibiotics, immunosuppressants combined with antibiotics, immunosuppressants alone, and antibiotics alone according to the individual clinical appraisal. Most of patients underwent surgery combined with immunosuppressants, and 30/107(28.0%) of them who accepted this treatment regimen suffered relapses, and patients with <italic toggle="yes">C. kroppenstedtii</italic> had a higher rate of recurrence (45%), but the rate of recurrence in those patients with <italic toggle="yes">C. kroppenstedtii</italic> who were treated with lipophilic antibiotics combined or alone was only 22% (11/50). Thus, lipophilic antibiotics may be essential for GM with <italic toggle="yes">C. kroppenstedtii</italic> infection when formulating treatment protocols, but more evidence and prospective studies are needed.</p><p id="Par25">Davis et al. reported that the average time to resolution was 5&#160;months (range 0&#8211;20) in their 120 patients identified with GM [<xref ref-type="bibr" rid="CR43">43</xref>]. In our study, the median time to complete remission was 5.0&#160;months as well, ranging from 1.0 to 24.0&#160;months, and patients in the CK group needed more time to achieve cure at their first treatment periods than those in the negative group. However, as reported in the literature, surgery that could easily change the time of achieving cure at their first treatment periods was performed not only depending on clinicians&#8217; judgement but also taking into account the patients&#8217; wishes [<xref ref-type="bibr" rid="CR28">28</xref>]. In our study, nearly 70% of patients underwent surgery. Therefore, although the time to complete remission in our study was different, we still need to be cautious. The diameter of the mass on the first medical consultation in our study was not completely consistent because the mass of GM grows and spreads rapidly [<xref ref-type="bibr" rid="CR50">50</xref>], and the time of their first medical consultation after the initial presentation of the mass was not completely consistent.</p><p id="Par26">To the best of our knowledge, this is the largest study in the literature discussing the clinical characteristics and therapeutic strategy of GM with <italic toggle="yes">C. kroppenstedtii</italic> infection. However, we still have some limitations of the current study. First was its retrospective nature, and missing some data of partial patients about the lactation time. Second, except for surgery combined with immunosuppressants there were too few patients treated with other protocols. Third, it is difficult to grow CK in the laboratory; therefore, those with "no CK" isolated might in fact be CK that just did not grow. In brief, our findings should be interpreted prudently and validated in future studies.</p></sec><sec id="Sec9"><title>Conclusions</title><p id="Par27">Sinus formation and a higher recurrence rate are intimately related to <italic toggle="yes">C. kroppenstedtii</italic> infection, and both may prove the possible important role of <italic toggle="yes">C. kroppenstedtii</italic> in the development and progression of GM. Although the time to complete remission at the first treatment period and the diameter of the mass at the first medical consultation were significantly different in our study, we still need to be cautious. In addition, lipophilic antibiotics may be considered for GM with <italic toggle="yes">C. kroppenstedtii</italic> infection when developing treatment plans.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>GM</term><def><p id="Par5">Granulomatous mastitis</p></def></def-item><def-item><term>CK</term><def><p id="Par6">
<italic toggle="yes">Corynebacterium </italic>
<italic toggle="yes">kroppenstedtii</italic>
</p></def></def-item><def-item><term>MALDI-TOF MS</term><def><p id="Par7">Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry</p></def></def-item><def-item><term>USG</term><def><p id="Par8">Ultrasonography</p></def></def-item><def-item><term>TRAM</term><def><p id="Par9">Transverse rectus abdominis musculocutaneous</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>ShunBo Li and Qian Huang contributed equally to this work and share first authorship.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>SL and PN conceived and designed the study and wrote the first draft of the manuscript. SL, QH, PS, ZL and LZ collected and cleaned the clinical data. SL, QH and XH analyzed the data, interpreted the results. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article/as supplementary information files.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par28">The Institutional Review Board of Chengdu Women&#8217;s and Children&#8217;s Central Hospital approved this study (reference number 2022(96)). Informed consent was waived by the local Ethics Committee of Chengdu Women&#8217;s and Children&#8217;s Central Hospital in view of the retrospective nature of the study and that all the procedures being performed were part of the routine medical care. The study followed the latest version of the Helsinki Declaration.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par29">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par30">ShunBo Li, Qian Huang, PeiPei Song, XiaoRong Han, ZeYu Liu, Lin Zhou, Ping Ning declare they have no conflict of interest.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>GB</given-names></name><name name-style="western"><surname>Paviour</surname><given-names>SD</given-names></name><name name-style="western"><surname>Musaad</surname><given-names>S</given-names></name><name name-style="western"><surname>Jones</surname><given-names>WO</given-names></name><name name-style="western"><surname>Holland</surname><given-names>DJ</given-names></name></person-group><article-title>A clinicopathological review of 34 cases of inflammatory breast disease showing an association between corynebacteria infection and granulomatous mastitis</article-title><source>Pathology</source><year>2003</year><volume>35</volume><issue>2</issue><fpage>109</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">12745457</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobinson</surname><given-names>HC</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>TP</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>ST</given-names></name><name name-style="western"><surname>Doogue</surname><given-names>MP</given-names></name><name name-style="western"><surname>Seaward</surname><given-names>L</given-names></name><name name-style="western"><surname>Werno</surname><given-names>AM</given-names></name></person-group><article-title>Antimicrobial treatment options for granulomatous mastitis caused by corynebacterium species</article-title><source>J Clin Microbiol</source><year>2015</year><volume>53</volume><issue>9</issue><fpage>2895</fpage><lpage>2899</lpage><pub-id pub-id-type="doi">10.1128/JCM.00760-15</pub-id><pub-id pub-id-type="pmid">26135858</pub-id><pub-id pub-id-type="pmcid">PMC4540898</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fujii</surname><given-names>M</given-names></name><name name-style="western"><surname>Mizutani</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sakuma</surname><given-names>T</given-names></name><etal/></person-group><article-title><italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> in granulomatous mastitis: analysis of formalin-fixed, paraffin-embedded biopsy specimens by immunostaining using low-specificity bacterial antisera and real-time polymerase chain reaction</article-title><source>Pathol Int</source><year>2018</year><volume>68</volume><issue>7</issue><fpage>409</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1111/pin.12683</pub-id><pub-id pub-id-type="pmid">29862601</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnstone</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Robson</surname><given-names>J</given-names></name><name name-style="western"><surname>Cherian</surname><given-names>SG</given-names></name><name name-style="western"><surname>Wan Sai Cheong</surname><given-names>J</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>K</given-names></name><name name-style="western"><surname>Bligh</surname><given-names>JF</given-names></name></person-group><article-title>Cystic neutrophilic granulomatous mastitis associated with Corynebacterium including <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic></article-title><source>Pathology</source><year>2017</year><volume>49</volume><issue>4</issue><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/j.pathol.2017.01.006</pub-id><pub-id pub-id-type="pmid">28442140</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Co</surname><given-names>M</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>V</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J</given-names></name><etal/></person-group><article-title>Idiopathic granulomatous mastitis: a 10-year study from a multicentre clinical database</article-title><source>Pathology</source><year>2018</year><volume>50</volume><issue>7</issue><fpage>742</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1016/j.pathol.2018.08.010</pub-id><pub-id pub-id-type="pmid">30389215</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Deng</surname><given-names>H</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><etal/></person-group><article-title>Clinical metagenomic analysis of bacterial communities in breast abscesses of granulomatous mastitis</article-title><source>Int J Infect Dis</source><year>2016</year><volume>53</volume><fpage>30</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2016.10.015</pub-id><pub-id pub-id-type="pmid">27777091</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ning</surname><given-names>P</given-names></name><etal/></person-group><article-title>A case management model for patients with granulomatous mastitis: a prospective study</article-title><source>BMC Womens Health</source><year>2022</year><volume>22</volume><issue>1</issue><fpage>143</fpage><pub-id pub-id-type="doi">10.1186/s12905-022-01726-w</pub-id><pub-id pub-id-type="pmid">35501850</pub-id><pub-id pub-id-type="pmcid">PMC9063211</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aghajanzadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Hassanzadeh</surname><given-names>R</given-names></name><name name-style="western"><surname>AlizadehSefat</surname><given-names>S</given-names></name><etal/></person-group><article-title>Granulomatous mastitis: presentations, diagnosis, treatment and outcome in 206 patients from the north of Iran</article-title><source>Breast</source><year>2015</year><volume>24</volume><issue>4</issue><fpage>456</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/j.breast.2015.04.003</pub-id><pub-id pub-id-type="pmid">25935828</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#350;ener Bah&#231;e</surname><given-names>Z</given-names></name><name name-style="western"><surname>Akta&#351;</surname><given-names>H</given-names></name></person-group><article-title>Patients with idiopathic granulomatous mastitis accompanied by erythema nodosum</article-title><source>Int J Clin Pract</source><year>2021</year><volume>75</volume><issue>4</issue><fpage>e13928</fpage><pub-id pub-id-type="doi">10.1111/ijcp.13928</pub-id><pub-id pub-id-type="pmid">33305438</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>SB</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>XR</given-names></name><name name-style="western"><surname>Liu</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Lv</surname><given-names>XL</given-names></name><name name-style="western"><surname>Ning</surname><given-names>P</given-names></name></person-group><article-title>Pregnancy associated granulomatous mastitis: clinical characteristics, management, and outcome</article-title><source>Breastfeed Med</source><year>2021</year><volume>16</volume><issue>9</issue><fpage>759</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1089/bfm.2021.0023</pub-id><pub-id pub-id-type="pmid">33872053</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erdal</surname><given-names>U</given-names></name></person-group><article-title>Response to Re: Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study?</article-title><source>ANZ J Surg</source><year>2020</year><volume>90</volume><issue>7&#8211;8</issue><fpage>1528</fpage><pub-id pub-id-type="doi">10.1111/ans.16054</pub-id><pub-id pub-id-type="pmid">33448596</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paviour</surname><given-names>S</given-names></name><name name-style="western"><surname>Musaad</surname><given-names>S</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>S</given-names></name><etal/></person-group><article-title>Corynebacterium species isolated from patients with mastitis</article-title><source>Clin Infect Dis</source><year>2002</year><volume>35</volume><issue>11</issue><fpage>1434</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1086/344463</pub-id><pub-id pub-id-type="pmid">12439810</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>MD</given-names></name><name name-style="western"><surname>Falsen</surname><given-names>E</given-names></name><name name-style="western"><surname>Akervall</surname><given-names>E</given-names></name><name name-style="western"><surname>Sj&#246;den</surname><given-names>B</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>A</given-names></name></person-group><article-title>Corynebacterium kroppenstedtii sp. nov. a novel corynebacterium that does not contain mycolic acids</article-title><source>Int J Syst Bacteriol</source><year>1998</year><volume>48</volume><fpage>1449</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.1099/00207713-48-4-1449</pub-id><pub-id pub-id-type="pmid">9828448</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabaja</surname><given-names>H</given-names></name><name name-style="western"><surname>Comba</surname><given-names>IY</given-names></name><name name-style="western"><surname>Pritt</surname><given-names>BS</given-names></name><name name-style="western"><surname>Abu Saleh</surname><given-names>OM</given-names></name></person-group><article-title>Granulomatous mastitis secondary to <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic></article-title><source>IDCases</source><year>2022</year><volume>28</volume><fpage>e01489</fpage><pub-id pub-id-type="doi">10.1016/j.idcr.2022.e01489</pub-id><pub-id pub-id-type="pmid">35392598</pub-id><pub-id pub-id-type="pmcid">PMC8980630</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kieffer</surname><given-names>P</given-names></name><name name-style="western"><surname>Dukic</surname><given-names>R</given-names></name><name name-style="western"><surname>Hueber</surname><given-names>M</given-names></name><etal/></person-group><article-title>A young woman with granulomatous mastitis: a corynebacteria may be involved in the pathogenesis of these disease</article-title><source>Rev Med Interne</source><year>2006</year><volume>27</volume><issue>7</issue><fpage>550</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.revmed.2006.03.033</pub-id><pub-id pub-id-type="pmid">16750284</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>A</given-names></name><name name-style="western"><surname>Hoda</surname><given-names>SA</given-names></name></person-group><article-title>Cystic neutrophilic granulomatous mastitis: Archetypal case associated with <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic></article-title><source>Breast J</source><year>2020</year><volume>26</volume><issue>12</issue><fpage>2407</fpage><lpage>2408</lpage><pub-id pub-id-type="doi">10.1111/tbj.14109</pub-id><pub-id pub-id-type="pmid">33216419</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renshaw</surname><given-names>AA</given-names></name><name name-style="western"><surname>Derhagopian</surname><given-names>RP</given-names></name><name name-style="western"><surname>Gould</surname><given-names>EW</given-names></name></person-group><article-title>Cystic neutrophilic granulomatous mastitis: an underappreciated pattern strongly associated with gram-positive bacilli</article-title><source>Am J Clin Pathol</source><year>2011</year><volume>136</volume><issue>3</issue><fpage>424</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1309/AJCP1W9JBRYOQSNZ</pub-id><pub-id pub-id-type="pmid">21846918</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>MG</given-names></name><name name-style="western"><surname>Leal</surname><given-names>S</given-names></name><name name-style="western"><surname>Plongla</surname><given-names>R</given-names></name><name name-style="western"><surname>Leone</surname><given-names>PA</given-names></name><name name-style="western"><surname>Gilligan</surname><given-names>PH</given-names></name></person-group><article-title>The brief case: recurrent granulomatous mastitis due to <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic></article-title><source>J Clin Microbiol</source><year>2016</year><volume>54</volume><issue>8</issue><fpage>1938</fpage><lpage>1941</lpage><pub-id pub-id-type="doi">10.1128/JCM.03131-15</pub-id><pub-id pub-id-type="pmid">27458268</pub-id><pub-id pub-id-type="pmcid">PMC4963526</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>C</given-names></name><name name-style="western"><surname>Lu</surname><given-names>FI</given-names></name><name name-style="western"><surname>Aftanas</surname><given-names>P</given-names></name><etal/></person-group><article-title>Whole genome sequence of <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> isolated from a case of recurrent granulomatous mastitis</article-title><source>IDCases</source><year>2020</year><volume>23</volume><fpage>e01034</fpage><pub-id pub-id-type="doi">10.1016/j.idcr.2020.e01034</pub-id><pub-id pub-id-type="pmid">33489755</pub-id><pub-id pub-id-type="pmcid">PMC7806865</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D'Alfonso</surname><given-names>TM</given-names></name><name name-style="western"><surname>Moo</surname><given-names>TA</given-names></name><name name-style="western"><surname>Arleo</surname><given-names>EK</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>E</given-names></name><name name-style="western"><surname>Antonio</surname><given-names>LB</given-names></name><name name-style="western"><surname>Hoda</surname><given-names>SA</given-names></name></person-group><article-title>Cystic neutrophilic granulomatous mastitis: further characterization of a distinctive histopathologic entity not always demonstrably attributable to corynebacterium infection</article-title><source>Am J Surg Pathol</source><year>2015</year><volume>39</volume><issue>10</issue><fpage>1440</fpage><lpage>1447</lpage><pub-id pub-id-type="doi">10.1097/PAS.0000000000000479</pub-id><pub-id pub-id-type="pmid">26200100</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neelja</surname><given-names>S</given-names></name><name name-style="western"><surname>Manish</surname><given-names>K</given-names></name><name name-style="western"><surname>Kanaujia</surname><given-names>PK</given-names></name><etal/></person-group><article-title>MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis</article-title><source>Front Microbiol</source><year>2015</year><volume>6</volume><fpage>791</fpage><pub-id pub-id-type="pmid">26300860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2015.00791</pub-id><pub-id pub-id-type="pmcid">PMC4525378</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>S</given-names></name><name name-style="western"><surname>Poon</surname><given-names>R</given-names></name><name name-style="western"><surname>Foo</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Novel selective medium for the isolation of <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> from heavily colonised clinical specimens</article-title><source>J Clin Pathol</source><year>2018</year><volume>71</volume><issue>9</issue><fpage>781</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1136/jclinpath-2017-204834</pub-id><pub-id pub-id-type="pmid">29593062</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Alfonso</surname><given-names>TM</given-names></name><name name-style="western"><surname>Ginter</surname><given-names>PS</given-names></name><name name-style="western"><surname>Shin</surname><given-names>SJ</given-names></name></person-group><article-title>A review of inflammatory processes of the breast with a focus on diagnosis in core biopsy samples</article-title><source>J Pathol Transl Med</source><year>2015</year><volume>49</volume><issue>4</issue><fpage>279</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.4132/jptm.2015.06.11</pub-id><pub-id pub-id-type="pmid">26095437</pub-id><pub-id pub-id-type="pmcid">PMC4508565</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Troxell</surname><given-names>ML</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>NT</given-names></name><name name-style="western"><surname>Doggett</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Cystic neutrophilic granulomatous mastitis: association with gram-positive bacilli and corynebacterium</article-title><source>Am J Clin Pathol</source><year>2016</year><volume>145</volume><issue>5</issue><fpage>635</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1093/ajcp/aqw046</pub-id><pub-id pub-id-type="pmid">27247368</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maung</surname><given-names>MH</given-names></name><name name-style="western"><surname>Bethune</surname><given-names>GC</given-names></name><name name-style="western"><surname>Patriquin</surname><given-names>G</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>PJ</given-names></name></person-group><article-title>Cystic neutrophilic granulomatous mastitis &#8211; a review of 12 consecutive cases from a Canadian center</article-title><source>Histopathology</source><year>2020</year><volume>77</volume><issue>5</issue><fpage>781</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1111/his.14187</pub-id><pub-id pub-id-type="pmid">32557756</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naik</surname><given-names>MA</given-names></name><name name-style="western"><surname>Korlimarla</surname><given-names>A</given-names></name><name name-style="western"><surname>Shetty</surname><given-names>ST</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>AM</given-names></name><name name-style="western"><surname>Pai</surname><given-names>SA</given-names></name></person-group><article-title>Cystic neutrophilic granulomatous mastitis: a clinicopathological study with 16s rRNA sequencing for the detection of corynebacteria in formalin-fixed paraffin-embedded tissue</article-title><source>Int J Surg Pathol</source><year>2020</year><volume>28</volume><issue>4</issue><fpage>371</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1177/1066896919896021</pub-id><pub-id pub-id-type="pmid">31870201</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>A</given-names></name><name name-style="western"><surname>Sung</surname><given-names>S</given-names></name><name name-style="western"><surname>Hoda</surname><given-names>SA</given-names></name><name name-style="western"><surname>Westblade</surname><given-names>LF</given-names></name><name name-style="western"><surname>D'Alfonso</surname><given-names>T</given-names></name><name name-style="western"><surname>Rao</surname><given-names>R</given-names></name></person-group><article-title>Cytomorphological features of cystic neutrophilic granulomatous mastitis on ThinPrep</article-title><source>Diagn Cytopathol</source><year>2018</year><volume>46</volume><issue>11</issue><fpage>966</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1002/dc.23988</pub-id><pub-id pub-id-type="pmid">30353674</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolfrum</surname><given-names>A</given-names></name><name name-style="western"><surname>K&#252;mmel</surname><given-names>S</given-names></name><name name-style="western"><surname>Theuerkauf</surname><given-names>I</given-names></name><name name-style="western"><surname>Pelz</surname><given-names>E</given-names></name><name name-style="western"><surname>Reinisch</surname><given-names>M</given-names></name></person-group><article-title>Granulomatous mastitis: a therapeutic and diagnostic challenge</article-title><source>Breast Care (Basel)</source><year>2018</year><volume>13</volume><issue>6</issue><fpage>413</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1159/000495146</pub-id><pub-id pub-id-type="pmid">30800035</pub-id><pub-id pub-id-type="pmcid">PMC6381909</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tauch</surname><given-names>A</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Natal</surname><given-names>I</given-names></name><name name-style="western"><surname>Soriano</surname><given-names>F</given-names></name></person-group><article-title>A microbiological and clinical review on <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic></article-title><source>Int J Infect Dis</source><year>2016</year><volume>48</volume><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2016.04.023</pub-id><pub-id pub-id-type="pmid">27155209</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fern&#225;ndez-Natal</surname><given-names>I</given-names></name><name name-style="western"><surname>Rodr&#237;guez-L&#225;zaro</surname><given-names>D</given-names></name><name name-style="western"><surname>Marrod&#225;n-Ciordia</surname><given-names>T</given-names></name><etal/></person-group><article-title>Characterization and antimicrobial susceptibility of one antibiotic-sensitive and one multidrug-resistant <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> strain isolated from patients with granulomatous mastitis</article-title><source>New Microbes New Infect</source><year>2016</year><volume>14</volume><fpage>93</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.nmni.2016.09.006</pub-id><pub-id pub-id-type="pmid">27818775</pub-id><pub-id pub-id-type="pmcid">PMC5078570</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fern&#225;ndez-Natal</surname><given-names>MI</given-names></name><name name-style="western"><surname>Soriano</surname><given-names>F</given-names></name><name name-style="western"><surname>Ariza-Miguel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Draft genome sequences of <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> CNM633/14 and CNM632/14, multidrug-resistant and antibiotic-sensitive isolates from nodules of granulomatous mastitis patients</article-title><source>Genome Announc</source><year>2015</year><volume>3</volume><issue>3</issue><fpage>e00525</fpage><lpage>e615</lpage><pub-id pub-id-type="doi">10.1128/genomeA.00525-15</pub-id><pub-id pub-id-type="pmid">25999560</pub-id><pub-id pub-id-type="pmcid">PMC4440974</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>SCY</given-names></name><name name-style="western"><surname>Poon</surname><given-names>RWS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JHK</given-names></name><etal/></person-group><article-title><italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> is an emerging cause of mastitis especially in patients with psychiatric illness on antipsychotic medication</article-title><source>Open Forum Infect Dis</source><year>2017</year><volume>4</volume><issue>2</issue><fpage>ofx096</fpage><pub-id pub-id-type="doi">10.1093/ofid/ofx096</pub-id><pub-id pub-id-type="pmid">28852671</pub-id><pub-id pub-id-type="pmcid">PMC5570011</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bi</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><etal/></person-group><article-title>Etiology of granulomatous lobular mastitis based on metagenomic next-generation sequencing</article-title><source>Int J Infect Dis</source><year>2021</year><volume>113</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2021.10.019</pub-id><pub-id pub-id-type="pmid">34673215</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kutsuna</surname><given-names>S</given-names></name><name name-style="western"><surname>Mezaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Nagamatsu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Two cases of granulomatous mastitis caused by <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> infection in nulliparous young women with hyperprolactinemia</article-title><source>Intern Med</source><year>2015</year><volume>54</volume><issue>14</issue><fpage>1815</fpage><lpage>1818</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.54.4254</pub-id><pub-id pub-id-type="pmid">26179543</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Fl&#232;che-Mat&#233;os</surname><given-names>A</given-names></name><name name-style="western"><surname>Berthet</surname><given-names>N</given-names></name><name name-style="western"><surname>Lomprez</surname><given-names>F</given-names></name><etal/></person-group><article-title>Recurrent Breast Abscesses due to <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic>, a Human Pathogen Uncommon in Caucasian Women</article-title><source>Case Rep Infect Dis</source><year>2012</year><volume>2012</volume><fpage>120968</fpage><pub-id pub-id-type="pmid">23008788</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2012/120968</pub-id><pub-id pub-id-type="pmcid">PMC3449112</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saraiya</surname><given-names>N</given-names></name><name name-style="western"><surname>Corpuz</surname><given-names>M</given-names></name></person-group><article-title><italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic>: a challenging culprit in breast abscesses and granulomatous mastitis</article-title><source>Curr Opin Obstet Gynecol</source><year>2019</year><volume>31</volume><issue>5</issue><fpage>325</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1097/GCO.0000000000000541</pub-id><pub-id pub-id-type="pmid">30946032</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tariq</surname><given-names>H</given-names></name><name name-style="western"><surname>Menon</surname><given-names>PD</given-names></name><name name-style="western"><surname>Fan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Detection of <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> in granulomatous lobular mastitis using real-time polymerase chain reaction and sanger sequencing on formalin-fixed paraffin-embedded tissues</article-title><source>Arch Pathol Lab Med</source><year>2022</year><volume>146</volume><issue>6</issue><fpage>749</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.5858/arpa.2021-0061-OA</pub-id><pub-id pub-id-type="pmid">34506619</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>XQ</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>JP</given-names></name><name name-style="western"><surname>Fu</surname><given-names>AS</given-names></name><etal/></person-group><article-title>New insights of <italic toggle="yes">Corynebacterium </italic><italic toggle="yes">kroppenstedtii</italic> in granulomatous lobular mastitis based on nanopore sequencing</article-title><source>J Invest Surg</source><year>2022</year><volume>35</volume><issue>3</issue><fpage>639</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1080/08941939.2021.1921082</pub-id><pub-id pub-id-type="pmid">34036894</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azizi</surname><given-names>A</given-names></name><name name-style="western"><surname>Prasath</surname><given-names>V</given-names></name><name name-style="western"><surname>Canner</surname><given-names>J</given-names></name><etal/></person-group><article-title>Idiopathic granulomatous mastitis: management and predictors of recurrence in 474 patients</article-title><source>Breast J</source><year>2020</year><volume>26</volume><issue>7</issue><fpage>1358</fpage><lpage>1362</lpage><pub-id pub-id-type="doi">10.1111/tbj.13822</pub-id><pub-id pub-id-type="pmid">32249491</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Q</given-names></name><etal/></person-group><article-title>A novel therapy for granulomatous lobular mastitis: local heat therapy</article-title><source>Exp Ther Med</source><year>2021</year><volume>22</volume><issue>4</issue><fpage>1156</fpage><pub-id pub-id-type="doi">10.3892/etm.2021.10590</pub-id><pub-id pub-id-type="pmid">34504601</pub-id><pub-id pub-id-type="pmcid">PMC8393844</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yau</surname><given-names>FM</given-names></name><name name-style="western"><surname>Macadam</surname><given-names>SA</given-names></name><name name-style="western"><surname>Kuusk</surname><given-names>U</given-names></name><name name-style="western"><surname>Nimmo</surname><given-names>M</given-names></name><name name-style="western"><surname>Van Laeken</surname><given-names>N</given-names></name></person-group><article-title>The surgical management of granulomatous mastitis</article-title><source>Ann Plast Surg</source><year>2010</year><volume>64</volume><issue>1</issue><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1097/SAP.0b013e3181a20cae</pub-id><pub-id pub-id-type="pmid">20023450</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>F</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Comparison of conservative versus surgical treatment protocols in treating idiopathic granulomatous mastitis: a meta-analysis</article-title><source>Breast Care (Basel)</source><year>2019</year><volume>15</volume><issue>4</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000503602</pub-id><pub-id pub-id-type="pmcid">PMC7490657</pub-id><pub-id pub-id-type="pmid">32982653</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>J</given-names></name><name name-style="western"><surname>Cocco</surname><given-names>D</given-names></name><name name-style="western"><surname>Matz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Re-evaluating if observation continues to be the best management of idiopathic granulomatous mastitis</article-title><source>Surgery</source><year>2019</year><volume>166</volume><issue>6</issue><fpage>1176</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2019.06.030</pub-id><pub-id pub-id-type="pmid">31400951</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#199;etinkaya</surname><given-names>G</given-names></name><name name-style="western"><surname>Kozan</surname><given-names>R</given-names></name><name name-style="western"><surname>Emral</surname><given-names>AC</given-names></name><name name-style="western"><surname>Tezel</surname><given-names>E</given-names></name></person-group><article-title>Granulomatous mastitis, watch and wait is a good option</article-title><source>Ir J Med Sci</source><year>2021</year><volume>190</volume><issue>3</issue><fpage>1117</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1007/s11845-020-02406-0</pub-id><pub-id pub-id-type="pmid">33078264</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godazandeh</surname><given-names>G</given-names></name><name name-style="western"><surname>Shojaee</surname><given-names>L</given-names></name><name name-style="western"><surname>Alizadeh-Navaei</surname><given-names>R</given-names></name><name name-style="western"><surname>Hessami</surname><given-names>A</given-names></name></person-group><article-title>Corticosteroids in idiopathic granulomatous mastitis: a systematic review and meta-analysis</article-title><source>Surg Today</source><year>2021</year><volume>51</volume><issue>12</issue><fpage>1897</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1007/s00595-021-02234-4</pub-id><pub-id pub-id-type="pmid">33590327</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>H</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Hua</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><name name-style="western"><surname>Weng</surname><given-names>Y</given-names></name></person-group><article-title>Ultrasound classification-guided minimally invasive rotary cutting in granulomatous lobular mastitis</article-title><source>BMC Womens Health</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>252</fpage><pub-id pub-id-type="doi">10.1186/s12905-020-01118-y</pub-id><pub-id pub-id-type="pmid">33198723</pub-id><pub-id pub-id-type="pmcid">PMC7670620</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Idiopathic granulomatous mastitis with skin rupture: a retrospective cohort study of 200 patients who underwent surgical and nonsurgical treatment</article-title><source>J Invest Surg</source><year>2021</year><volume>34</volume><issue>7</issue><fpage>810</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1080/08941939.2019.1696905</pub-id><pub-id pub-id-type="pmid">31818161</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tekg&#246;z</surname><given-names>E</given-names></name><name name-style="western"><surname>&#199;olak</surname><given-names>S</given-names></name><name name-style="western"><surname>&#199;inar</surname><given-names>M</given-names></name><name name-style="western"><surname>Yilmaz</surname><given-names>S</given-names></name></person-group><article-title>Treatment of idiopathic granulomatous mastitis and factors related with disease recurrence</article-title><source>Turk J Med Sci</source><year>2020</year><volume>50</volume><issue>5</issue><fpage>1380</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.3906/sag-2003-93</pub-id><pub-id pub-id-type="pmid">32394683</pub-id><pub-id pub-id-type="pmcid">PMC7491308</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barreto</surname><given-names>DS</given-names></name><name name-style="western"><surname>Sedgwick</surname><given-names>EL</given-names></name><name name-style="western"><surname>Nagi</surname><given-names>CS</given-names></name><name name-style="western"><surname>Benveniste</surname><given-names>AP</given-names></name></person-group><article-title>Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings</article-title><source>Breast Cancer Res Treat</source><year>2018</year><volume>171</volume><issue>3</issue><fpage>527</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1007/s10549-018-4870-3</pub-id><pub-id pub-id-type="pmid">29971624</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oran</surname><given-names>E&#350;</given-names></name><name name-style="western"><surname>G&#252;rdal</surname><given-names>S&#214;</given-names></name><name name-style="western"><surname>Yankol</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Management of idiopathic granulomatous mastitis diagnosed by core biopsy: a retrospective multicenter study</article-title><source>Breast J</source><year>2013</year><volume>19</volume><issue>4</issue><fpage>411</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1111/tbj.12123</pub-id><pub-id pub-id-type="pmid">23663101</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>